Elevate the Digital Patient Experience

Digital patient experience platforms: Why now?

Clinical advances and digital innovations are dynamically reshaping the digital patient experience:

• Specialty products and personalized therapies are driving the need for more integrated and sophisticated patient support services. Life sciences companies are looking for ways to help providers using their therapeutics to deliver optimal care. This can, in turn, help patients better manage their disease and complex medication regimens while reducing complications and related costs.
• New digital patient experience platforms and ecosystems are intensifying patient expectations for support services and solutions that are coordinated, convenient, and personalized.¹
• Disruptions in traditional engagement practices are creating opportunities for life sciences companies to help the care team expedite, record, and track interactions to enable patient access to products and drive therapy adherence.

Many biopharmaceutical and medical device companies have historically outsourced their patient engagement functions to “hub” service providers. However, technology is driving a paradigm shift: Life sciences leaders increasingly want to directly manage the patient experience and engagement channels to deliver better care, monitor progress, enhance outcomes, and demonstrate value beyond the therapy itself.

As a result, we are seeing the emergence of fully in-house models, as well as hybrids, in which the biopharma or device company uses CHC for Life Sciences to “own” key portions of the patient journey and outsources less strategic call center functions. We are also seeing hub vendors purchase CHC for Life Sciences to enhance their patient engagement capabilities.